drugset / Trial / NCT07544251

Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.

NCT07544251

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is being done to help better understand how the gut and skin bacteria of the body change when people with acne are treated with Sarecycline or Doxycycline. The bacteria in the gut and on the skin will be studied to see how each treatment may affect them and whether they change the profile of the bacteria that is present.

Timeline

Start
2026-04-20
Primary completion
2027-04
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 100 mg
Subject Sarecycline Small molecule 1.5 mg/kg Oral
Subject Sarecycline Small molecule 60 mg Oral
Subject Sarecycline Small molecule 100 mg Oral
Subject Sarecycline Small molecule 150 mg Oral

Indications